A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

NCT00220363 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer